The immunohistochemistry test detects the folate receptor 1 protein, which is over-expressed in most ovarian cancers.

On Tuesday, company revealed that its subcutaneous formulation of Keytruda has aced a phase 3 trial, demonstrating ...

These jobs will propel the province towards being a global leader in biomanufacturing and life sciences. MISSISSAUGA, ON, Nov ...

Roche has secured CE mark approval for its immunohistochemistry (IHC) companion diagnostic test, VENTANA FOLR1 (FOLR1-2.1) ...

The Executive Vice-President, Diagnostics, Africa at Roche Diagnostics, Dr. Allan Pamba stated this in a statement to ...

Government funding will support 250 jobs in health-care technology at a Mississauga-based company. Hoffman-La Roche Limited’s ...

Wish4Life Foundation, a US-based non-government organisation (NGO) dedicated to the care of children battling with cancer, is ...

Health care providers may include doctors, nurses, nursing assistants, social workers and lab technicians. Age may be ...

AbbVie has announced the European Commission (EC) has granted marketing authorization for ELAHERE (mirvetuximab soravtansine) ...

AbbVie receives European marketing approval for Elahere for the treatment of platinum-resistant ovarian cancer: North Chicago, Illinois Tuesday, November 19, 2024, 10:00 Hrs [IST] ...